NIH-funded research R01 grant

Investigating how gut microbes affect heart disease risk

Official title: Gut microbial metabolites and risk of coronary heart disease: a prospective, multiethnic, metabolomic study

Funded at Vanderbilt University Medical Center · NIH-10654667 · Data updated 2026-11-12

This study is looking at how certain substances made by gut bacteria from the food we eat might affect the risk of heart disease, and it aims to find new ways to help prevent it for people from different backgrounds and diets.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startJuly 15, 2020
Project endJune 30, 2025
Funding year2023
Award (this year)$822,424
NIH project number5R01HL149779-04
Project IDNIH-10654667 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults from diverse ethnic backgrounds who are at risk for coronary heart disease.

Less likely to help

Patients who do not have any risk factors for coronary heart disease or those under 21 years old may not benefit from this research.

What this research studies

This research explores the relationship between gut microbial metabolites and the risk of coronary heart disease (CHD). By analyzing metabolites like trimethylamine N-oxide (TMAO) and equol, which are derived from diet and produced by gut bacteria, the study aims to identify new biomarkers and potential therapeutic targets for CHD prevention. The research will involve diverse populations to ensure findings are applicable across different ethnicities and dietary habits, enhancing the understanding of how gut health influences heart disease risk.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing coronary heart disease through dietary and microbiome interventions.

How similar studies have gone: Previous studies have shown promising results linking gut microbial metabolites to cardiovascular health, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Yu, Danxia — Vanderbilt University Medical Center
  • Study coordinator: Yu, Danxia

Related research

Other NIH-funded projects on the same topics.

  • Pay-what-you-can cafes and heart health in people with high blood pressure and food insecurity

    This project tests whether eating at pay-what-you-can cafes improves blood pressure and heart- disease related outcomes for hypertensive adults who face food insecurity.

    NIH research Texas A&m Agrilife Research · College Station, UNITED STATES · NIH-11448249

  • Apolipoprotein Proteoforms and Heart Health

    This grant aims to understand how different chemical changes to apolipoproteins relate to cholesterol, obesity, insulin resistance, and risk of heart disease in people.

    NIH research Northwestern University · Chicago, United States · NIH-11417166

  • Metal exposures and heart disease: how genes and mixtures shape risk

    A large study from NYU aims to understand how exposure to arsenic and other metals, together with genetic factors, influence the risk of coronary heart disease in diverse adults.

    NIH research New York University School of Medicine · New York, United States · NIH-11372279

  • How stress-linked gene changes may raise heart disease risk

    This project looks at whether stress-related chemical changes on DNA in blood immune cells help explain higher heart disease risk in people exposed to chronic psychosocial stress.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11326344

  • Genetic clues to blood fats and heart disease progression

    Researchers are studying how genetic differences affect blood lipid levels and heart disease risk so doctors can tailor prevention for people at different ages.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11293111

  • PFAS chemicals, blood lipoproteins, and coronary heart disease risk

    Researchers will look at whether common environmental chemicals called PFAS are linked to specific blood lipoproteins and higher risk of coronary heart disease in adults.

    NIH research Brigham and Women's Hospital · Boston, United States · NIH-11285433

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.